SCHEMBL5282925

SCHEMBL5282925

[CH2]n1c(=O)oc2cccc(C)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
DAO P14920 1/20 0.35
MAPK1 P28482 2/20 0.34
USP2 O75604 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
TP53 P04637 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3354467 0.79 POLB (0.41) POLBKMT2AALDH1A1NPSR1DAO
SCHEMBL5537334 0.78 ALDH1A1 (0.35) ALDH1A1NPSR1MAPK1USP2HPGD
SCHEMBL5541186 0.78 ALDH1A1 (0.41) POLBKMT2AALDH1A1NPSR1MAPK1
SCHEMBL5543640 0.78 AR (0.36) POLBALDH1A1NPSR1DAOMAPK1
SCHEMBL2149188 0.73 ALDH1A1 (0.45) POLBKMT2AALDH1A1NPSR1HPGD
SCHEMBL14199038 0.71 POLB (0.41) POLBKMT2AALDH1A1NPSR1MAPK1
SCHEMBL12494895 0.70 ADRA1D (0.41) POLBKMT2AALDH1A1MAPK1USP2
SCHEMBL5558972 0.69 HPGD (0.60) POLBKMT2AALDH1A1MAPK1HPGD
SCHEMBL9715954 0.68 POLB (0.39) POLBKMT2AALDH1A1NPSR1MAPK1
SCHEMBL3543457 0.68 TSHR (0.57) ALDH1A1NPSR1MAPK1USP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO claimed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US claimed
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 POLB 3888/4885KMT2A 4422/4885ALDH1A1 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.